FDA approval is based on results from the landmark Phase III ATOMIC study, published in The New England Journal of Medicine, which showed Tecentriq plus chemotherapy reduced the risk of disease recurrence or death by 50% compared to chemotherapy alone
An affiliate of KKR & Co. Inc., a leading global investment firm and investor in Crescent, has agreed to purchase 40,000,000 shares as part of the offering HOUSTON–(BUSINESS WIRE)–Crescent Energy Company (“Crescent” or the “Company”) (NYSE: CRGY) today announced the
SAN DIEGO–(BUSINESS WIRE)–$DUOL #DUOL–Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons who purchased Duolingo, Inc. (NASDAQ: DUOL) Class A common stock between May 2, 2025 and February 26, 2026,
Humorous brand awareness campaign with an e.l.f. twist spotlights Save Your e.l.f. Hypochlorous Mist that helps soothe stressed skin and beyond OAKLAND, Calif.–(BUSINESS WIRE)–e.l.f. SKIN, a brand from e.l.f. Beauty (NYSE: ELF), answers community mist-mergencies in an all-new brand awareness
SAN DIEGO–(BUSINESS WIRE)–$BULL #BULL–Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired Webull Corporation (NASDAQ: BULL) securities between April 26, 2025 and October 6,
